MedPath

Determination of minimally important difference (MID) of EQ5D VAS and respiratory function in patients underwent lung resection for lung cancer

Not Applicable
Recruiting
Conditions
lung cancer
Registration Number
JPRN-UMIN000037864
Lead Sponsor
Department of Thoracic Surgery, Hitachi Medical Education and Research Center, University of Tsukuba
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
250
Inclusion Criteria

Not provided

Exclusion Criteria

1)reading disability of Japanese, 2)severe visual disorder, 3)cognitive impairment or impairment of decision-making ability, 4)pathological diagnosis except for lung cancer, 5)in the following cases, this protocol will be terminated, i)postoperative relapse, ii)metachronous lung cancer, iii)multiple primary cancer of other organ requiring major surgery, iv)disease or injury deteriorating QOL significantly

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
MID of EQ5D VAS and respiratory function one year after lung resection.
Secondary Outcome Measures
NameTimeMethod
MID of EORTC QLQ C30 GHS and 6MWT
© Copyright 2025. All Rights Reserved by MedPath